Contact Us
Drug Search Results
More Filters [+]

Dimenhydrinate

Alternative Names: dimenhydrinate, dimenhidrinato, gravol
Latest Update: 2024-11-07
Latest Update Note: News Article

Product Description

Dimenhydrinate is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. Dimenhydrinate is in a class of medications called antihistamines. It works by preventing problems with body balance. (Sourced from: https://medlineplus.gov/druginfo/meds/a607046.html)

Mechanisms of Action: H1 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Dominican Republic | Ecuador | Egypt | Estonia | France | Germany | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Italy | Korea | Latvia | Lebanon | Malaysia | Malta | Mexico | Morocco | New Zealand | Pakistan | Peru | Philippines | Portugal | Russia | Serbia | Singapore | South Africa | Spain | Sri Lanka | Sweden | Taiwan | Thailand | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dimenhydrinate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

11/07/2024

News Article

 Cellev8 Nutrition Shareholder Update

11/06/2024

News Article

 BrandSpark Most Trusted Awards announces 12th annual Most Trusted brands in Canada for 2025

07/26/2024

News Article

 Motion Sickness Drugs Market size is set to grow by USD 139.5 million from 2024-2028, Availability of over-the-counter (OTC) drugs to boost the market growth, Technavio

01/26/2024

News Article

 Dyslexia Treatments Market Outlook Projected CAGR of 6.8% Leading to US$ 11.9 Billion by 2030, Persistence Market Research

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions